<p>Summary of tumor incidence in OPN<sup>+/+</sup> and OPN<sup>−/−</sup> mice upon injecting with SP and non-SP cells.</p
<p>(A) Injection of 300, 3 000 or 30 000 cells. (B) Injection of 1 000, 10 000 or 100 000 cells. Whe...
a<p>Each experiment was conducted with tumor tissue derived from a different ovarian cancer patient....
<p>“Tumor incidence” indicates the average incidence of tumors in each mice (6 mice in each group, 6...
<p>(A) Injection sites of nonobese diabetic (NOD)/severe combined immunodeficiency (SCID) mice. Hema...
<p>A, Table presentation of the tumorigenic potential of H460 SP and non-SP cells. Three parameters ...
<p>Evaluation of the incidence of tumors in NOD/SCID mice implanted with different numbers of BCSCs ...
<p>A and B, injection sites of NOD/SCID mice at 6 weeks after inoculation with freshly sorted SP or ...
<p>A, Tumor incidence from 3 experiments. Equal numbers of sex matched SCID mice were injected s.c. ...
<p>N/A, not applied. All data are presented as the number of mice developed tumors/the number of mic...
<p>Abbreviations: SP, side population; NSP, non-SP; NOD, nonobese diabetic; SCID, severe combined im...
<p>(A) Column chart showing the tumor incidence in each group following the injection of 1×10<sup>5<...
<p>NOD/SCID mice were subcutaneously injected with hPSC, ihPSC, and Hela cells (8 x 10<sup>6</sup> c...
<p>Tumor incidence in <i>Ntv-a Arf</i>-/- mice injected with PDGF-B+X (P+X) or PDGF-B+HRG (P+H) RCAS...
<p>(A) Formation of tumors following injection of CD24+ cells. Groups of six NOD/SCID mice were inje...
<p>(<b>A</b>) B16F10 cells were injected subcutaneously into OPN<sup>+/+</sup> and OPN<sup>−/−</sup>...
<p>(A) Injection of 300, 3 000 or 30 000 cells. (B) Injection of 1 000, 10 000 or 100 000 cells. Whe...
a<p>Each experiment was conducted with tumor tissue derived from a different ovarian cancer patient....
<p>“Tumor incidence” indicates the average incidence of tumors in each mice (6 mice in each group, 6...
<p>(A) Injection sites of nonobese diabetic (NOD)/severe combined immunodeficiency (SCID) mice. Hema...
<p>A, Table presentation of the tumorigenic potential of H460 SP and non-SP cells. Three parameters ...
<p>Evaluation of the incidence of tumors in NOD/SCID mice implanted with different numbers of BCSCs ...
<p>A and B, injection sites of NOD/SCID mice at 6 weeks after inoculation with freshly sorted SP or ...
<p>A, Tumor incidence from 3 experiments. Equal numbers of sex matched SCID mice were injected s.c. ...
<p>N/A, not applied. All data are presented as the number of mice developed tumors/the number of mic...
<p>Abbreviations: SP, side population; NSP, non-SP; NOD, nonobese diabetic; SCID, severe combined im...
<p>(A) Column chart showing the tumor incidence in each group following the injection of 1×10<sup>5<...
<p>NOD/SCID mice were subcutaneously injected with hPSC, ihPSC, and Hela cells (8 x 10<sup>6</sup> c...
<p>Tumor incidence in <i>Ntv-a Arf</i>-/- mice injected with PDGF-B+X (P+X) or PDGF-B+HRG (P+H) RCAS...
<p>(A) Formation of tumors following injection of CD24+ cells. Groups of six NOD/SCID mice were inje...
<p>(<b>A</b>) B16F10 cells were injected subcutaneously into OPN<sup>+/+</sup> and OPN<sup>−/−</sup>...
<p>(A) Injection of 300, 3 000 or 30 000 cells. (B) Injection of 1 000, 10 000 or 100 000 cells. Whe...
a<p>Each experiment was conducted with tumor tissue derived from a different ovarian cancer patient....
<p>“Tumor incidence” indicates the average incidence of tumors in each mice (6 mice in each group, 6...
DOI
Add to ORKG